Floatz logo

cs01

ORR,OS,PFS

The Second Hospital of Shandong Universitymonoclonal_antibodyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the ORR,OS,PFS cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

cs01 is also rated in:

Locally Advanced or Metastatic Solid TumorsDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →